User profiles for Thomas F. Tropea
Thomas F TropeaUniversity of Pennsylvania Verified email at uphs.upenn.edu Cited by 1172 |
GPNMB confers risk for Parkinson's disease through interaction with α-synuclein
Many risk loci for Parkinson’s disease (PD) have been identified by genome-wide association
studies (GWASs), but target genes and mechanisms remain largely unknown. We linked …
studies (GWASs), but target genes and mechanisms remain largely unknown. We linked …
Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease
Background Neurofilament light chain protein (NfL) is a promising biomarker of neurodegeneration.
Objectives To determine whether plasma and CSF NfL (1) associate with motor or …
Objectives To determine whether plasma and CSF NfL (1) associate with motor or …
A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology
J Wie, Z Liu, H Song, TF Tropea, L Yang, H Wang… - Nature, 2021 - nature.com
Lysosomes have fundamental physiological roles and have previously been implicated in
Parkinson’s disease 1 , 2 , 3 , 4 – 5 . However, how extracellular growth factors communicate …
Parkinson’s disease 1 , 2 , 3 , 4 – 5 . However, how extracellular growth factors communicate …
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia
Objective Common variants near TMEM106B associate with risk of developing frontotemporal
dementia (FTD). Emerging evidence suggests a role for TMEM106B in neurodegenerative …
dementia (FTD). Emerging evidence suggests a role for TMEM106B in neurodegenerative …
Cav1. 2 L-type Ca2+ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area …
AMPA receptor (AMPAR) plasticity at glutamatergic synapses in the mesoaccumbal
dopaminergic pathway has been implicated in persistent cocaine-induced behavioral responses; …
dopaminergic pathway has been implicated in persistent cocaine-induced behavioral responses; …
Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting
The pathological hallmark of neurodegenerative diseases is the formation of toxic oligomers
by proteins such as alpha-synuclein (aSyn) or microtubule-associated protein tau (Tau). …
by proteins such as alpha-synuclein (aSyn) or microtubule-associated protein tau (Tau). …
Enhanced CREB and DARPP‐32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated …
TF Tropea, BE Kosofsky… - Journal of …, 2008 - Wiley Online Library
Environment‐induced relapse is a major concern in drug addiction because of the strong
associations formed between drug reward and environment. Cocaine‐conditioned place …
associations formed between drug reward and environment. Cocaine‐conditioned place …
Genetic prediction of impulse control disorders in Parkinson's disease
Objective To develop a clinico‐genetic predictor of impulse control disorder (ICD) risk in
Parkinson's disease (PD). Methods In 5770 individuals from three PD cohorts (the 23andMe, Inc.…
Parkinson's disease (PD). Methods In 5770 individuals from three PD cohorts (the 23andMe, Inc.…
Enhancing VTA Cav1. 3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus …
A Martínez-Rivera, J Hao, TF Tropea, TP Giordano… - Molecular …, 2017 - nature.com
Genetic factors significantly influence susceptibility for substance abuse and mood disorders.
Rodent studies have begun to elucidate a role of Ca v 1.3 L-type Ca 2+ channels in …
Rodent studies have begun to elucidate a role of Ca v 1.3 L-type Ca 2+ channels in …
[HTML][HTML] Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention
Parkinson disease (PD) is highly prevalent among neurodegenerative diseases, affecting a
diverse patient population. Despite a general willingness of patients to participate in clinical …
diverse patient population. Despite a general willingness of patients to participate in clinical …